These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7483762)

  • 1. Intestinal immunization of mice with antigen conjugated to anti-MHC class II antibodies.
    Estrada A; McDermott MR; Underdown BJ; Snider DP
    Vaccine; 1995 Jul; 13(10):901-7. PubMed ID: 7483762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal antigen targeting to MHC class II molecules primes local IgA and serum IgG antibody responses in mice.
    Snider DP; Underdown BJ; McDermott MR
    Immunology; 1997 Mar; 90(3):323-9. PubMed ID: 9155636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses.
    Guéry JC; Neagu M; Rodriguez-Tarduchy G; Adorini L
    J Exp Med; 1993 May; 177(5):1461-8. PubMed ID: 8478615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC.
    Carayanniotis G; Barber BH
    Nature; 1987 May 7-13; 327(6117):59-61. PubMed ID: 3472080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.
    Ilkovitch D; Ostrand-Rosenberg S
    Cancer Immunol Immunother; 2004 Jun; 53(6):525-32. PubMed ID: 14730400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the adjuvant-free serological response to protein antigens coupled to antibodies specific for class II MHC determinants.
    Carayanniotis G; Barber BH
    Vaccine; 1990 Apr; 8(2):137-44. PubMed ID: 2336874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
    Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
    Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen presentation by a mouse duodenal epithelial cell line (MODE-K).
    Vidal K; Grosjean I; Kaiserlian D
    Adv Exp Med Biol; 1995; 371A():225-8. PubMed ID: 8525912
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of the adjuvant-independent antibody response to immunotargeting. Target structure dependence, isotype distribution, and induction of long term memory.
    Skea DL; Barber BH
    J Immunol; 1993 Oct; 151(7):3557-68. PubMed ID: 8376792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin.
    Snider DP; Marshall JS; Perdue MH; Liang H
    J Immunol; 1994 Jul; 153(2):647-57. PubMed ID: 8021502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro.
    Zhong G; Reis e Sousa C; Germain RN
    J Exp Med; 1997 Aug; 186(5):673-82. PubMed ID: 9271583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of synthetic peptides by anti-class II MHC monoclonal antibodies induces specific adjuvant-free IgG responses in vivo.
    Carayanniotis G; Vizi E; Parker JM; Hodges RS; Barber BH
    Mol Immunol; 1988 Sep; 25(9):907-11. PubMed ID: 2850498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with antigen bound to bispecific antibody induces antibody that is restricted in epitope specificity and contains antiidiotype.
    Snider DP
    J Immunol; 1992 Feb; 148(4):1163-70. PubMed ID: 1371133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein.
    Zhong G; Reis e Sousa C; Germain RN
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13856-61. PubMed ID: 9391117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antigen immunogenicity induced by bispecific antibodies.
    Snider DP; Kaubisch A; Segal DM
    J Exp Med; 1990 Jun; 171(6):1957-63. PubMed ID: 2351931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class II-targeted antigen is superior to CD40-targeted antigen at stimulating humoral responses in vivo.
    Frleta D; Demian D; Wade WF
    Int Immunopharmacol; 2001 Feb; 1(2):265-75. PubMed ID: 11360928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mAb against hen egg-white lysozyme regulate its presentation to CD4(+) T cells.
    Guermonprez P; Lo-Man R; Sedlik C; Rojas MJ; Poljak RJ; Leclerc C
    Int Immunol; 1999 Nov; 11(11):1863-72. PubMed ID: 10545490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.
    Matousek MP; Nedrud JG; Harding CV
    J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.